|
BAL0891 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: TTK-CS-101
New Haven, Connecticut1 trial
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Yale New Haven Hospital
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.